Jean Michel Guys

Jean Michel Guys

Auto-generated profile, based on publicly available information

Jean Michel Guys

Department of Pediatric Surgery, Hôpital Timone, Marseille, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Journal of Urology
Verified
Journal Article
Closed access
JGJean-Michel Guys
Jean-Michel Guys
JBJean Breaud
Jean Breaud
GHGéraldine Hery
Géraldine Hery
ACAntoine Camerlo
Antoine Camerlo
HHHéléne Le Hors
Héléne Le Hors
PLPascal De Lagausie
Pascal De Lagausie
We report the long-term results of endoscopic injection of PDMS in correcting urinary incontinence in children with neurogenic bladder. We performed a single center, retrospective study of patients receiving endoscopic injections of PDMS. All procedures were performed as outpatient surgery using endoscopic guidance. Procedure tolerance was assessed at 15 days, and efficacy was evaluated at 3 months, 6 months and annually thereafter. Success was defined as periods of dryness between bladder voiding of more than 4 hours during the daytime without the need to wear pads. Improvement was defined as periods of dryness greater than 2 and less than 4 hours with occasional protection. A total of 49 children (21 boys and 28 girls) have received 1 or more injections of PDMS since 1995. Etiology was spina bifida in 41 patients (84%), with surgery (enterocystoplasty and/or bladder neck reconstruction) performed previously in 27 patients. Mean patient age was 14 years (standard deviation 4.8). Mean volume of PDMS per treatment was 3.6 ml. At the end of the 6-year mean followup 16 patients (33%) were continent and 7 (14%) were improved. Continence was unchanged in the remaining 26 patients (53%). After a significant deterioration of the results the outcome remained almost unchanged from 18 months of followup. Bladder neck surgery, bladder hyperactivity if medically controlled and gender have no influence statistically on the long-term results. Injection of PDMS for incontinence of neurogenic origin is a reliable technique that achieves long-term continence in almost a third of the patients. This procedure can be used either as first line treatment or in addition to other surgical techniques. The initial success of the procedure seems predictive of success in the long term, and results are stable after 18 months of followup.

1 December 2011 in Scandinavian Journal of Surgery
Verified
Journal Article
Open access
PDF file
JGJ. M. Guys
J. M. Guys
GHG. Hery
G. Hery
MHM. Haddad
M. Haddad
CBC. Borrionne
C. Borrionne
Diagnosis of neurogenic bladder is straightforward in children with myelomeningocele. However, recognition is more difficult in patients with occult dysraphism or central nervous system disorders since clinico-anatomical correlations are poor. Careful clinical examination and urodynamic exploration are mandatory for diagnosis and follow-up. Even if urinary leak is the first symptom, the main goal of the pediatric surgeon must be to preserve the upper urinary tract. The ideal protection strategy consists of ensuring that micturition is voluntary and complete and that the bladder capacity is sufficient with adequate compliance and sphincter outlet resistances. Balancing these functions requires a combination of medical and surgical treatment. A variety of techniques can be used depending on gender and age of the patient and social environment. In most cases, intermittent bladder catheterization is necessary to obtain complete evacuation of the bladder. Bladder capacity can be increased by anticholinergic drugs, injection of botulinum toxin into the bladder, and augmentation cystoplasty. Augmentation of bladder outlet resistances requires endoscopic injection of bulking agents, surgical bladder neck reconstruction and urethral lengthening, bladder neck suspension, and artificial urinary sphincter. In difficult cases, continent cystostomy with closure of the bladder neck can achieve definitive continence. At the beginning endoscopic treatment combining anti reflux procedure, injection of the bladder neck and botulinum toxin can be considered as a “total endoscopic management” and should be our first line. Other techniques are under evaluation. Sacral neuromodulation has given promising results. Artificial tissue engineering will probably be used in the next future. Management of neurogenic bladder is not limited to urological considerations. Orthopedic, digestive, and sexual problems must also be taken into account in order to obtain an “acceptable quality of life”.

1 August 2012 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
ASAurelien Scalabre
Aurelien Scalabre
GGGuillaume Gorincour
Guillaume Gorincour
GHGeraldine Hery
Geraldine Hery
MGMarc Gamerre
Marc Gamerre
JGJean-Michel Guys
Jean-Michel Guys
PLPascal de Lagausie
Pascal de Lagausie

1 February 2006 in Annales d'Urologie
Verified
Journal Article
Closed access
JGJ.-M. Guys
J.-M. Guys
ACA. Camerlo
A. Camerlo
GHG. Hery
G. Hery

5 September 2013 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
GHGeraldine Hery
Geraldine Hery
APAlain Potier
Alain Potier
GGGuillaume Gorincour
Guillaume Gorincour
BGBéatrice Giudicelli
Béatrice Giudicelli
NPNicole Philip
Nicole Philip
JLJean-Francois Lecompte
Jean-Francois Lecompte
Purpose Cystic lesions are common findings during prenatal ultrasonography but their prenatal and postnatal prognosis is difficult to establish because of some regress spontaneously. The purpose of this study was to identify putative criteria to predict regression of partially or completely cystic lesions detected by prenatal ultrasound. Methods Prenatal ultrasound features of thoracic or abdominal cystic lesions were retrospectively analyzed. Ovarian and urological lesions were not included in this study. Results A total of 57 cystic lesions were studied. Of the 57 lesion, 36 lesions including 10 abdominal (43.5%) and 26 thoracic (76.5%) lesions required surgical resection. Of the 57 lesions, 10 persistent lesions after birth were only monitored. Eleven lesions including eight abdominal (34.7%) and three thoracic (8.8%) lesions regressed prenatally (p = 0.02). Regressing abdominal lesions consistently presented as solitary lesions with a homogenous aspect. Only one abdominal lesion showed a multilobulated aspect. Two regressing thoracic lesions were purely cystic and one lesion presented a heterogeneous aspect. Conclusion Regression of cystic lesions detected by prenatal ultrasound scan was more likely for lesions in abdominal (mainly adrenal or splenic lesions) than thoracic locations. The likelihood of regression was highest for purely cystic abdominal lesions.

5 October 2006
Verified
Book Chapter
Closed access
PDF file
ROReinier J. Opsomer
Reinier J. Opsomer
JGJean-Michel Guerit
Jean-Michel Guerit
MMMichèle Mayer
Michèle Mayer